Daiwa Securities Group
RLYB icon

Daiwa Securities Group’s Rallybio RLYB Stock Holding History

Daiwa Securities Group’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed -$1K – 1374
2022
Q3 		$1K Hold
12
– – ﹤0.01% 1312
2022
Q2 		$1K Hold
12
– – ﹤0.01% 1319
2022
Q1 		$1K Hold
12
– – ﹤0.01% 1335
2021
Q4 		$1K Buy
+12
New +$1.4K ﹤0.01% 1356

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Daiwa Securities Group's RLYB Position: Q4 2022 in Review

Daiwa Securities Group sold out of Rallybio (RLYB) in Q4 2022, closing a stake of 12 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in RLYB in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 57 funds tracked by Wall St. Rank hold RLYB as of Q4 2022.

  • Daiwa Securities Group reported no remaining Rallybio position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 12 Rallybio shares in Q4 2022, an estimated $1K.
  • Daiwa Securities Group first reported a position in Rallybio in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's Rallybio position peaked at $1K in Q3 2022.
  • 57 funds tracked by Wall St. Rank held Rallybio as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.